指南与共识重症综合管理与镇静镇痛

围手术期静脉血栓栓塞症预防:2024年法国围手术期止血工作组(GIHP)与法国麻醉与重症医学会(SFAR)、法国血栓与止血学会(SFTH)及法国血管医学会(SFMV)合作制定的指南

Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (
指南 / 共识 · Anaesth Crit Care Pain Med · 2024-10-22
一句话结论2024年GIHP等多学会指南共形成78条围手术期VTE预防推荐,其中27条为GRADE 1、41条为GRADE 2、10条为专家意见,所有推荐均获专家强烈共识。

该指南由法国围手术期止血工作组(GIHP)与法国麻醉与重症医学会(SFAR)、法国血栓与止血学会(SFTH)及法国血管医学会(SFMV)的40名专家共同更新,替代2011年版推荐。专家以PICO格式定义问题,依据GRADE系统进行文献回顾并形成推荐,再经投票确定推荐强度。最终共形成78条推荐、分17个部分,涵盖患者相关VTE危险因素、手术类型、极端体重、肾功能不全、机械预防及远端深静脉血栓;27条为高证据水平(GRADE 1)、41条为低证据水平(GRADE 2)、10条为专家意见,所有推荐均获专家强烈共识。指南未涵盖心脏手术、神经外科和产科的围手术期血栓预防。

要点

  • 2024年GIHP/SFAR/SFTH/SFMV指南共形成78条围手术期VTE预防推荐,分17个部分,所有推荐均获专家强烈共识。
  • 78条推荐中27条为高证据水平(GRADE 1),41条为低证据水平(GRADE 2),10条为专家意见。
  • 推荐内容涵盖患者相关VTE危险因素、手术类型、极端体重、肾功能不全、机械预防及远端深静脉血栓。
  • 指南未涵盖心脏手术、神经外科和产科的围手术期血栓预防。
  • 指南帮助权衡围手术期VTE风险(包括手术相关风险和患者相关风险)与药物或机械血栓预防的不良反应(尤其是抗血栓药物引起的出血风险)及费用。

适用人群与场景

  • 接受手术且存在静脉血栓栓塞症(VTE)风险的患者;指南未涵盖心脏手术、神经外科和产科的围手术期血栓预防。

研究设计与关键结果

  • 该指南由40名专家(GIHP、SFAR、SFTH和SFMV)以PICO格式定义问题,依据GRADE系统进行文献回顾并形成推荐,再经投票确定推荐强度。
  • 共形成78条推荐、分17个部分,涵盖患者相关VTE危险因素、手术类型、极端体重、肾功能不全、机械预防及远端深静脉血栓。
  • 78条推荐中27条为高证据水平(GRADE 1),41条为低证据水平(GRADE 2),10条为专家意见;所有推荐均获专家强烈共识。
  • 指南未涵盖心脏手术、神经外科和产科的围手术期血栓预防。

证据类型、等级与局限

  • 证据类型:指南;采用GRADE系统进行证据分级,推荐强度经专家投票确定。
  • 推荐证据等级:27条为GRADE 1,41条为GRADE 2,10条为专家意见;所有推荐均获专家强烈共识。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 指南帮助权衡围手术期VTE风险(包括手术相关风险和患者相关风险)与药物或机械血栓预防的不良反应(尤其是抗血栓药物引起的出血风险)及费用。
  • 该指南不涵盖心脏手术、神经外科和产科的围手术期血栓预防。

指南或共识出处

  • 指南名称:Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surg
  • 发布机构:法国围手术期止血工作组(GIHP)、法国麻醉与重症医学会(SFAR)、法国血栓与止血学会(SFTH)、法国血管医学会(SFMV)。
  • 年份:2024年。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Any surgical procedure carries a risk for venous thromboembolism (VTE), albeit variable. Improvements in medical and surgical practices and the shortening of care pathways due to the development of day surgery and enhanced recovery after surgery, have reduced the perioperative risk for VTE.

OBJECTIVE: A collaborative working group of experts in perioperative haemostasis updated in 2024 the recommendations for the Prevention of perioperative venous thromboembolism published in 2011.

METHODS: The addressed questions were defined by 40 experts (GIHP, SFAR, SFTH and SFMV) and formulated in a PICO format. They performed the literature review and formulated recommendations according to the Grading of GRADE system. Recommendations were then validated by a vote determining the strength of each recommendation. Of note, these recommendations do not cover all surgical specialties. Especially, thromboprophylaxis in cardiac surgery, neurosurgery and obstetrics is not addressed.

RESULTS: 78 recommendations were formalized into 17 sections, including patient-related VTE risk factors, types of surgery, extreme body weight, renal impairment, mechanical prophylaxis, distal deep vein thrombosis; 27 were found to have a high level of evidence (GRADE 1) and 41 a low level of evidence (GRADE 2) and 10 were expert opinion. All had strong agreement among the experts.

CONCLUSIONS: These guidelines help to weigh the perioperative risk for VTE (which includes the risk associated to surgery and the patient-related risk) against the adverse effects of thromboprophylaxis, either pharmacological or mechanical. This includes particularly the bleeding risk induced by antithrombotic drugs as well as costs.

来源:Anaesth Crit Care Pain Med,查看原文。版权归原作者所有。

参考来源

  1. Godier A, Lasne D, Pernod G, et al. Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network. Anaesth Crit Care Pain Med. 2024. PMID: 39447869. doi:10.1016/j.accpm.2024.101446

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。